首页> 外国专利> Device for determining resistance to pharmaceuticals, used particularly for selection of anticancer agents, comprises an array of nucleic acid sequences or derived proteins from specific genes

Device for determining resistance to pharmaceuticals, used particularly for selection of anticancer agents, comprises an array of nucleic acid sequences or derived proteins from specific genes

机译:用于确定对药物的抗性的设备,特别是用于选择抗癌剂的设备,包括一系列核酸序列或来自特定基因的衍生蛋白

摘要

Device for determining resistance to pharmaceuticals, particularly chemotherapeutic agents; comprises, on a carrier, at least one selection of molecules (I) that (a) are cDNA or RNA, and/or their fragments, that correspond to 224 tabulated genes or (b) peptides and/or proteins that bind specifically to the proteins encoded by the tabulated genes. An independent claim is also included for a method for preparing the device.
机译:用于确定对药物特别是化学治疗剂的抗性的装置;在载体上包含至少一种选择的分子(I),其(a)是cDNA或RNA和/或其片段,它们对应于224个列表化的基因或(b)特异性结合该分子的肽和/或蛋白质列表基因编码的蛋白质。还包括用于准备该设备的方法的独立权利要求。

著录项

  • 公开/公告号DE10351717A1

    专利类型

  • 公开/公告日2005-06-16

    原文格式PDF

  • 申请/专利权人 OLIGENE GMBH;

    申请/专利号DE2003151717

  • 发明设计人 LAGE HERMANN;

    申请日2003-10-31

  • 分类号C12Q1/68;

  • 国家 DE

  • 入库时间 2022-08-21 22:01:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号